ACE inhibitor and spironolactone — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Hyperkalaemia
Both medicines can increase potassium, so monitoring and dose review are required. In this vignette, "Hyperkalaemia" is the safest single best answer. The other options are less appropriate because they miss the key clinical risk, conflict with UK medicines guidance, or delay needed review.
Reference: BNF